DYN·26818M108·US·Common Stock·Healthcare - Biotechnology-13D/G
DYN (DYNE THERAPEUTICS INC) is held by 117 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($247.4M), BlackRock, Inc. ($212.1M), FMR LLC ($161.5M). Net institutional sentiment: Mixed.
See how DYN's score breaks down across 4 SEC sources
Showing 1-20 of 135
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer